According to AcelRx Pharmaceuticals
's latest financial reports the company has $10.41 M in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2022-12-31 | $21.81 M | -160.78% |
2021-12-31 | $-35.9 M | -35.62% |
2020-12-31 | $-55.75 M | 34.6% |
2019-12-31 | $-41.42 M | -1073.85% |
2018-12-31 | $4.25 M | -111.65% |
2017-12-31 | $-36.51 M | 584.07% |
2016-12-31 | $-5.34 M | -116.12% |
2015-12-31 | $33.11 M | -29.03% |
2014-12-31 | $46.65 M | -36.23% |
2013-12-31 | $73.15 M | 116.15% |
2012-12-31 | $33.84 M | 93.77% |
2011-12-31 | $17.46 M | -126.51% |
2010-12-31 | $-65.9 M | 24.34% |
2009-12-31 | $-53 M | 58.97% |
2008-12-31 | $-33.34 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
![]() Cara Therapeutics
CARA | $0.10 B | 945.51% | ๐บ๐ธ USA |